Itokin (Itopride Hydrochloride)

Itopride acts by blocking dopamine D2 receptors in the gut and inhibiting acetylcholinesterase. This dual action raises acetylcholine levels, stimulating smooth‑muscle contraction and promoting coordinated gastric emptying and intestinal transit.

The dosage of Itokin is determined by the prescribing healthcare professional based on the individual’s condition, age, renal function and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for itopride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before starting Itokin.

To request Itokin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Itokin (itopride) differs from agents such as metoclopramide by combining dopamine D2 antagonism with acetylcholinesterase inhibition, which may result in a favorable side‑effect profile and effective gastric motility enhancement. Choice of therapy depends on clinical response, tolerability and physician judgment.

Itokin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Itokin is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional. Timing relative to meals may be advised by the prescriber.

Serious adverse events, although rare, can include severe allergic reactions such as anaphylaxis, extrapyramidal symptoms like tremor or rigidity, cardiac arrhythmias, and significant liver injury. Patients should seek immediate medical attention if they experience any of these symptoms.

Itokin is contraindicated in individuals with known hypersensitivity to itopride hydrochloride or any of the tablet’s excipients. Caution is also advised for patients with severe cardiac disease, uncontrolled hepatic impairment, or those taking medications that may cause dangerous interactions.